{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-254153","form_type":"8-K","ticker":"TVTX","cik":"0001438533","company_name":"Travere Therapeutics, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.456520+00:00","generated_at":"2026-05-30T02:45:57.028629+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Travere Therapeutics prices $125M public offering of 7.8M shares at $16.00/share","bullets":["Priced 7,812,500 shares at $16.00 per share; gross proceeds of $125.0M.","Net proceeds expected ~$117.0M after underwriting discounts and expenses.","Underwriters have 30-day option to purchase up to 1,171,875 additional shares.","Closing expected November 12, 2024; Jefferies and Leerink Partners are joint book-runners.","Proceeds for general corporate purposes including commercialization and R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-254153","json":"https://secwatch.observer/filing/0001193125-24-254153.json","markdown":"https://secwatch.observer/filing/0001193125-24-254153.md","text":"https://secwatch.observer/filing/0001193125-24-254153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438533/000119312524254153/0001193125-24-254153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438533/000119312524254153/d632981d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:45:57.028629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}